A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY OF FEVIPIPRANT ONCE DAILY PLUS STANDARD-OF-CARE (SOC) FOR ASSESSMENT OF THE EFFICACY IN REDUCTION OF NASAL POLYPS SIZE IN PATIENTS WITH NASAL POLYPOSIS AND CONCOMITANT ASTHMA
- Registry ID
- CQAW039A2322
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- NOVARTIS PHARMACEUTICALS CANADA INC
- Start date
- 2019-04-17
- Last update
- 2018-12-05
Conditions
Related clinical trials
- A DOUBLE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) WHO PARTICIPATED IN EITHER EFC18418 OR EFC18419 CLINICAL STUDIES
- A MULTINATIONAL, INVESTIGATOR-INITIATED, PARALLEL GROUP, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3B SUPERIORITY TRIAL ASSESSING THE EFFECT OF DUPILUMAB ON INDUCING CLINICAL REMISSION OUTCOMES IN AT-RISK TYPE-2 INFLAMMATORY ASTHMA (HOTHOT)
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A STUDY OF ARO-RAGE INHALATION SOLUTION TO ASSESS EFFICACY ON SMALL AIRWAY DYSFUNCTION IN ALLERGEN-INDUCED MILD ASTHMA
- A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, 52-WEEK STUDY, TO INVESTIGATE THE EFFICACY AND SAFETY OF BRENIPATIDE COMPARED WITH PLACEBO FOR THE TREATMENT OF ADULT PARTICIPANTS WITH UNCONTROLLED MODERATE TO SEVERE ASTHMA
- PAXT: PULMONARY IMAGING OF MILD ASTHMA USING 129-XENON MRI AND TC-99-LABELED-CARBON-IMAGING (TC99CIMAGING)
- REVERSE LUNG AIRWAY AND VASCULAR REMODELING IN ASTHMA REMISSION (RENORM)
View on source registry